First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR MutationsSEQUIST, Lecia V; MARTINS, Renato G; KUHLMANN, Georgiana L et al.Journal of clinical oncology. 2008, Vol 26, Num 15, pp 2442-2448, issn 0732-183X, 7 p.Article

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung CancerKOIVUNEN, Jussi P; MERMEL, Craig; LEE, Jinseon et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4275-4283, issn 1078-0432, 9 p.Article

Phase ii clinical trial of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancerJACKMAN, David M; YEAP, Beow Y; FREIDLIN, Boris et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 760-766, issn 0732-183X, 7 p.Article